Cargando…
An Ionic Liquid Ablation Agent for Local Ablation and Immune Activation in Pancreatic Cancer
Pancreatic ductal adenocarcinoma rapidly acquires resistance to chemotherapy, remaining a fatal disease. Immunotherapy is one of the breakthroughs in cancer treatment, which includes immune checkpoint inhibitors, chimeric antigen receptor T‐cell immunotherapy, and neoantigen vaccines. However, immun...
Autores principales: | Huang, Junming, Wang, Meng, Zhang, Fu, Shao, Shiyi, Yao, Zhuo, Zhao, Xinyu, Hu, Qida, Liang, Tingbo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10074093/ https://www.ncbi.nlm.nih.gov/pubmed/36698308 http://dx.doi.org/10.1002/advs.202206756 |
Ejemplares similares
-
Engineered a dual-targeting biomimetic nanomedicine for pancreatic cancer chemoimmunotherapy
por: Wang, Meng, et al.
Publicado: (2022) -
Gallbladder Adenosquamous Cancer with Situs Inversus Totalis: A Case Report and Literature Review
por: Huang, Junming, et al.
Publicado: (2021) -
Esophageal neuroendocrine carcinoma complicated with unexpected hyperprocalcitonin: Case report and literature review
por: Hu, Qida, et al.
Publicado: (2018) -
Local Ablative Strategies for Ductal Pancreatic Cancer (Radiofrequency Ablation, Irreversible Electroporation): A Review
por: Paiella, Salvatore, et al.
Publicado: (2016) -
Hypofractionated ablative radiotherapy for locally advanced pancreatic cancer
por: Crane, Christopher H.
Publicado: (2016)